Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: ImmunityBio Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Celldex Therapeutics Inc. June 25, 202699.3%
-
ImmunityBio Inc. June 9, 202699.7%
-
ImmunityBio Inc. June 18, 202599.5%
-
Celldex Therapeutics Inc. June 5, 202599.7%
-
Celldex Therapeutics Inc. June 13, 202498.9%
-
ImmunityBio Inc. June 11, 202499.8%
-
Celldex Therapeutics Inc. June 15, 202398.9%
-
ImmunityBio Inc. June 13, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 2, 2026 | ImmunityBio Inc. | Option exercise | +55,979 | $2.98 | $166,817 |
| Oct 2, 2026 | ImmunityBio Inc. | Open-market sale | −81,056 | $10.50 | $851,088 |
| Jul 2, 2026 | ImmunityBio Inc. | Option exercise | +55,979 | $2.98 | $166,817 |
| Jul 2, 2026 | ImmunityBio Inc. | Open-market sale | −131,210 | $9.50 | $1,246,495 |
Questions about Cheryl Cohen
What boards is Cheryl Cohen on?
Cheryl Cohen sits on the boards of Celldex Therapeutics Inc. and ImmunityBio Inc.
How long has Cheryl Cohen served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.